Literature DB >> 12090973

Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.

Peter Ravdin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12090973     DOI： 10.1016/S0140-6736(02)09111-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  ATAC trial: reporting interim results is not helpful.

Authors:  Heather Goodare; Clare Dimmer; Kathy Page
Journal:  BMJ       Date:  2003-06-14

2.  MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy.

Authors:  George C Bobustuc; Joshua S Smith; Sreeram Maddipatla; Sheila Jeudy; Arati Limaye; Beth Isley; Maria-Lourdes M Caparas; Susan M Constantino; Nikita Shah; Cheryl H Baker; Kalkunte S Srivenugopal; Said Baidas; Santhi D Konduri
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

3.  A new day dawns: women without oestrogen or is a balance best?

Authors:  V Craig Jordan
Journal:  Breast Cancer Res       Date:  2002-09-10       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.